2-(PYRIDIN-3-YL)-1,3-OXAZOLE-5-CARBALDEHYDE
- $45 - $1786
- Product name: 2-(PYRIDIN-3-YL)-1,3-OXAZOLE-5-CARBALDEHYDE
- CAS: 1267182-01-3
- MF: C9H6N2O2
- MW: 174.16
- EINECS:
- MDL Number:MFCD19347393
- Synonyms:2-(PYRIDIN-3-YL)-1,3-OXAZOLE-5-CARBALDEHYDE;5-Oxazolecarboxaldehyde, 2-(3-pyridinyl)-;2-(Pyridin-3-yl)oxazole-5-carbaldehyde
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- TRC
Package
- 10mg
- 50mg
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM323649
- Product description2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95%
- Packaging1g
- Price$561
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11303418
- Product description2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95+%
- Packaging1g
- Price$594
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11303418
- Product description2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95+%
- Packaging5g
- Price$1786
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP999760
- Product description2-(Pyridin-3-Yl)-1,3-Oxazole-5-Carbaldehyde
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP999760
- Product description2-(Pyridin-3-Yl)-1,3-Oxazole-5-Carbaldehyde
- Packaging50mg
- Price$175
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM323649 | 2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95% | 1g | $561 | 2021-12-16 | Buy |
Crysdot | CD11303418 | 2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95+% | 1g | $594 | 2021-12-16 | Buy |
Crysdot | CD11303418 | 2-(Pyridin-3-yl)oxazole-5-carbaldehyde 95+% | 5g | $1786 | 2021-12-16 | Buy |
TRC | P999760 | 2-(Pyridin-3-Yl)-1,3-Oxazole-5-Carbaldehyde | 10mg | $45 | 2021-12-16 | Buy |
TRC | P999760 | 2-(Pyridin-3-Yl)-1,3-Oxazole-5-Carbaldehyde | 50mg | $175 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|